Sio Capital Management, LLC - CTI BIOPHARMA CORP ownership

Back to all holdings Add to watchlist

CTI BIOPHARMA CORP's ticker is CTIC and the CUSIP is 12648L601. A total of 84 filers reported holding CTI BIOPHARMA CORP in Q2 2018. The put-call ratio across all filers is 0.51 and the average weighting 0.2%.

Links
Filings
External links
Quarter-by-quarter ownership
Sio Capital Management, LLC ownership history of CTI BIOPHARMA CORP
ValueSharesWeighting
Q1 2023$2,210,204
+11.4%
526,239
+59.5%
1.09%
+49.1%
Q4 2022$1,983,300
+1163.2%
330,000
+944.3%
0.73%
+742.5%
Q2 2018$157,000–31,600–0.09%–
 Download
Other shareholders

There were no reported owners of CTI BIOPHARMA CORP in Q2 2018.

NameSharesValueWeighting ↓
View complete list of CTI BIOPHARMA CORP shareholders